Speculation Surfaces Could SpaceX Intel Merge in a 1 Trillion Deal Borosil Glass Works Surges Over 200 in One Year on Strong Revenue and EBIDTA Growth Ferrari Shares Slide Following Unveiling of First Fully Electric Vehicle Prediction Markets Signal Rising Odds of Fed Rate Hike by July 2027 Spain Blocks Polymarket and Kalshi Over Gambling License Requirements Arm Holdings Surges as Bernstein Initiates Coverage with 300 Price Target Highlighting CPU Renaissance Role Contineum Therapeutics Inc CTNM Q1 2026 Earnings ClinicalStage Biotech Reports Narrower Loss Shares Dip Alcon ALC Q1 2026 Earnings EPS Beats Estimates as Surgical and Vision Care Segments Drive Profitability EVGO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Ridgetech Inc RDGT Q3 2011 Earnings EPS Falls Short of Estimates Stock Declines AMH Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Execution TVGN Q4 2025 Earnings NarrowerThanExpected Loss but No Revenue Growth Keeps Stock Under Pressure Cornerstone Strategic Investment Fund CLM Posts Modest Gains as Shares Hold Above Key Support Ellomay Capital ELLO Declines 233 as Stock Tests Key Support Levels Kemper Corporation KMPR Declines Nearly 2 Approaching Key Support at 2578 Murphy Oil Corporation MUR Slides as Crude Weakness Weighs on Energy Sector Silvercorp Metals Shares Slide Over 4 Amid Broader Sector Weakness Indian Stocks in Focus as Gift Nifty Hints at Positive Open Meesho Max Financial Services GIPCL Eyed WEAV Q1 2026 Earnings EPS Surprise of 2931 Drives Positive Market Reaction Franklin Financial Services FRAF Slides 177 as Stock Tests Key Support Level ADI Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction BLZE Q1 2026 Earnings EPS Misses Estimate as Revenue Data Unavailable CTMX Q1 2026 Earnings Narrower Loss Surprises Analysts ICE Q1 2026 Earnings Earnings Beat Estimates on 29 Surprise Shares Edge Higher AMSF Q1 2026 Earnings EPS Misses Estimates as Stock Declines LMAT Q1 2026 Earnings EPS Beats Estimates by Narrow Margin Stock Declines Slightly Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress